Sebastian Hilscher

9PUBLICATIONS
52CO-AUTHORS
Biologically active moleculesMolecular targetsCheminformatics and quantitative structure-activity relationshipsInterior designHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 16, 2026
Capsaicin-Inspired Hydroxamate Hybrids as Selective HDAC6 Inhibitors with Antiproliferative Activity in Hematological Malignancies.

Lara Gimenez Borges, Thais Nascimento de Oliveira Alves, Sandra Valeria Vassiliades

|Nov 03, 2025
Substrate-Guided Development of HDAC11-Selective Inhibitors Featuring α‑Amino Amide Zinc-Binding Groups.

Sebastian Hilscher, Marat Meleshin, Fady Baselious

|Dec 16, 2024
Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment.

Karoline B Waitman, Holli-Joi Martin, Jorge A E G Carlos

|Sep 18, 2024
Development of new pyrazoles as class I HDAC inhibitors: Synthesis, molecular modeling, and biological characterization in leukemia cells.

Francesco Berluti, Fady Baselious, Sven Hagemann

|Jul 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity.

Fady Baselious, Sebastian Hilscher, Sven Hagemann

|Jul 02, 2024
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal

Pageof 2

Frequent Collaborators

8 joint publications

Wolfgang Sippl

5 joint publications

Mike Schutkowski

4 joint publications

Fady Baselious

3 joint publications

Cyril Barinka